GPIHBP1: a new chylomicronemia gene

Bibliography

• Beigneux A, Davies B, Gin P et al.: Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab. 5, 279–291 (2007).
   Google Scholar
• Shows that mice lacking GPIHBP1 have chylomicronemia. Article also demonstrates that GPIHBP1 is located along the luminal surface of capillaries, and that this molecule binds lipoprotein lipase and chylomicrons.
   Google Scholar
• Wang J, Hegele RA: Homozygous missense mutation (G56R) in glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPI-HBP1) in two siblings with fasting chylomicronemia (MIM 144650). Lipids Health Dis. 6, 23 (2007).
   Google Scholar
• Genomic DNA of 160 patients with chylomicronemia were screened (and more than 1200 control subjects) for coding-region mutations in GPIHBP1. One subject with chylomicronemia who was homozgygous for a G56R mutation in GPIHBP1 was identified. A sibling with chylomicronemia was also homozygous for the same mutation.
   Google Scholar
• Havel RJ, Gordon RS Jr: Idiopathic hyperlipemia: metabolic studies in an affected family. J. Clin. Invest. 39, 1777–1790 (1960)
   Google Scholar
• Breckenridge WC, Little JA, Steiner G, Chow A, Poapst M: Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N. Engl. J. Med. 298, 1265–1273 (1978)
   Google Scholar
• Ito Y, Azrolan N, O’Connell A, Walsh A, Breslow JL: Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science 249, 790–793 (1990)
   Google Scholar
• Pennacchio LA, Olivier M, Hubacek JA et al.: An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294, 169–173 (2001)
   Google Scholar
• Koishi R, Ando Y, Ono M et al.: Angptl3 regulates lipid metabolism in mice. Nat. Genet. 30, 151–157 (2002)
   Google Scholar
• Yoshida K, Shimizugawa T, Ono V, Furukawa H: Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J. Lipid Res. 43, 1770–1772 (2002)
   Google Scholar
• Young S, Davies BSJ, Fong LG et al.: GPIHBP1 – an endothelial cell molecule required for the lipolytic processing of chylomicrons. Curr. Opin Lipidol. 18, 389–396 (2007)
   Google Scholar
• Havel RJ, Kane JP: Introduction: structure and metabolism of plasma lipoproteins. In: The Metabolic and Molecular Bases of Inherited Disease. Scriver CR, Beaudet AL, Sly WS et al. (Eds). McGraw-Hill, NY, USA 2705–2716 (2001)
   Google Scholar
• Kane JP, Havel RJ: Disorders of the biogenesis and secretion of lipoproteins containing the B apolipoproteins. In: The Metabolic and Molecular Bases of Inherited Disease. Scriver CR, Beaudet AL, Sly WS et al. (Eds). McGraw-Hill, NY, USA 2717–2752 (2001)
   Google Scholar
• Olivecrona T, Bengtsson-Olivecrona G: Lipoprotein lipase and hepatic lipase. Curr. Opin. Lipidol. 1, 222–230 (1990)
   Google Scholar
• Bengtsson G, Olivecrona T: Activation of lipoprotein lipase by apolipoprotein CII. Demonstration of an effect of the activator on the binding of the enzyme to milk-fat globules. FEBS Lett. 147, 183–187 (1982)
   Google Scholar
• Bengtsson G, Olivecrona T: Lipoprotein lipase: some effects of activator proteins. Eur. J. Biochem. 106, 549–555 (1980)
   Google Scholar
• Bengtsson G, Olivecrona T: Apolipoprotein CII enhances hydrolysis of monoglycerides by lipoprotein lipase, but the effect is abolished by fatty acids. FEBS Lett. 106, 345–348 (1979)
   Google Scholar
• Weisgraber KH, Rall SC Jr, Mahley RW, Milne RW, Marcel YL, Sparrow JT: Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3. J. Biol. Chem. 261, 2068–2076 (1986)
   Google Scholar
• Klinger MM, Margolis RU, Margolis RK: Isolation and characterization of the heparan sulfate proteoglycans of brain. Use of affinity chromatography on lipoprotein lipaseagarose. J. Biol. Chem. 260, 4082–4090 (1985)
   Google Scholar
• Goldberg IJ: Lipoprotein lipase and lipolysis: Central roles in lipoprotein metabolism and atherogenesis. J. Lipid Res. 37, 693–707 (1996)
   Google Scholar
• Mahley RW, Ji Z-S: Remnant lipoprotein metabolism: key pathways involving cellsurface heparan sulfate proteoglycans and apolipoprotein E. J. Lipid Res. 40, 1–16 (1999)
   Google Scholar
• Mullick AE, Deckelbaum RJ, Goldberg IJ, Al-Haideri M, Rutledge JC: Apolipoprotein E and lipoprotein lipase increase triglyceride-rich particle binding but decrease particle penetration in arterial wall. Arterioscler. Thromb. Vasc. Biol. 22, 2080–2085 (2002)
   Google Scholar
• Plump AS, Smith JD, Hayek T et al.: Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71, 343–353 (1992)
   Google Scholar
• Mahley RW: Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622–630 (1988). 23. Herz J: The LDL-receptor-related protein – portrait of a multifunctional receptor. Curr. Opin. Lipidol. 4, 107–113 (1993)
   Google Scholar
• Ishibashi S, Herz J, Maeda N, Goldstein JL, Brown MS: The two-receptor model of lipoprotein clearance: Tests of the hypothesis in ‘knockout’ mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc. Natl Acad. Sci. USA 91, 4431–4435 (1994)
   Google Scholar
• Choi SY, Fong LG, Kirven MJ, Cooper AD: Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo. J. Clin. Invest. 88, 1173–1183 (1991)
   Google Scholar
• Yu KCW, Chen W, Cooper AD: LDL receptor-related protein mediates cellsurface clustering and hepatic sequestration of chylomicron remnants in LDLR-deficient mice. J. Clin. Invest. 107, 1387–1394 (2001)
   Google Scholar
• Willnow TE, Sheng Z, Ishibashi S, Herz J: Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist. Science 264, 1471–1474 (1994)
   Google Scholar
• Bensadoun A: Lipoprotein lipase. Annu. Rev. Nutr. 11, 217–237 (1991)
   Google Scholar
• Brunzell JD, Deeb SS: Familial lipoprotein lipase deficiency, apo C-II deficiency, and hepatic lipase deficiency. In: The Metabolic and Molecular Bases of Inherited Disease. Scriver CR, Beaudet AL, Sly WS et al. (Eds). McGraw-Hill, NY, USA 2789–2816 (2001) 30. Oka K, Wang-Iverson P, Paterniti JR Jr, Brown WV: Interaction of lipoprotein lipase with heparin. Ann. NY Acad. Sci. 556, 173–180 (1989)
   Google Scholar
• Rutledge JC, Woo MM, Rezai AA, Curtiss LK, Goldberg IJ: Lipoprotein lipase increases lipoprotein binding to the artery wall and increases endothelial layer permeability by formation of lipolysis products. Circ. Res. 80, 819–828 (1997)
   Google Scholar
• Ioka RX, Kang M-J, Kamiyama S et al.: Expression cloning and characterization of a novel glycosylphosphatidylinositolanchored high density lipoprotein-binding protein, GPI-HBP1. J. Biol. Chem. 278, 7344–7349 (2003). oo Use of expression cloning to search for molecules that confer upon Chinese hamster ovary cells the ability to bind to HDL. One of the molecules identified in this screen was GPIHBP1, a glycosylphosphatidylinositolanchored protein with a Ly-6 motif. It was suggested that GPIHBP1 was likely important in reverse cholesterol transport. 33. Strauss, JG, Frank S, Kratky D et al.: Adenovirus-mediated rescue of lipoprotein lipase-deficient mice. Lipolysis of triglyceride-rich lipoproteins is essential for high density lipoprotein maturation in mice. J. Biol. Chem. 276, 36083–36090 (2001)
   Google Scholar
• Redgrave TG: Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons. J. Clin. Invest. 49, 465–471 (1970)
   Google Scholar
• Herz J, Qiu S-Q, Oesterle A, de Silva HV, Shafi S, Havel RJ: Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor. Proc. Natl Acad. Sci. USA 92, 4611–4615 (1995)
   Google Scholar
• Kompiang IP, Bensadoun A, Yang MW: Effect of an anti-lipoprotein lipase serum on plasma triglyceride removal. J. Lipid Res. 17, 498–505 (1976)
   Google Scholar
• Ginsberg HN, Goldberg IJ: Disorders of lipoprotein metabolism. In: Harrison’s Principles of Internal Medicine (14th Edition). Fauci AS, Braunwald E, Isselbacher KJ et al. (Eds). McGraw-Hill, NY, USA 2138–2149 (1998)
   Google Scholar
• Ginsberg HN, Goldberg IJ: Disorders of lipoprotein metabolism. In: Harrison’s Principles of Internal Medicine (15th Edition). Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (Eds). McGraw-Hill, NY, USA 2245–2257 (2001)
   Google Scholar
• Wong H, Schotz MC: The lipase gene family. J. Lipid Res. 43, 993–999 (2002)
   Google Scholar
• Ben-Zeev O, Doolittle MH, Davis RC, Elovson J, Schotz MC: Maturation of lipoprotein lipase. Expression of full catalytic activity requires glucose trimming but not translocation to the cis-Golgi compartment. J. Biol. Chem. 267, 6219–6227 (1992)
   Google Scholar
• Reue K, Doolittle MH: Naturally occurring mutations in mice affecting lipid transport and metabolism. J. Lipid Res. 37, 1387–1405 (1996)
   Google Scholar
• Briquet-Laugier V, Ben-Zeev O, White A, Doolittle MH: cld and lec23 are disparate mutations that affect maturation of lipoprotein lipase in the endoplasmic reticulum. J. Lipid Res. 40, 2044–2058 (1999)
   Google Scholar
• Peterfy M, Ben-Zeev O, Mao HZ et al.: Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia. Nat. Genet. 39, 1483–1487 (2007)
   Google Scholar
• Faustinella F, Smith LC, Semenkovich CF, Chan L: Structural and functional roles of highly conserved serines in human lipoprotein lipase. Evidence that serine 132 is essential for enzyme catalysis. J. Biol. Chem. 266, 9481–9485 (1991)
   Google Scholar
• Wong H, Davis RC, Nikazy J, Wang KL, Schotz MC: Hepatic- and lipoprotein lipase domain function: assessment by chimeric lipases. Circulation I-608 (1992)
   Google Scholar
• Sendak RA, Melford K, Kao A, Bensadoun A: Identification of the epitope of a monoclonal antibody that inhibits heparin binding of lipoprotein lipase: new evidence for a carboxyl-terminal heparinbinding domain. J. Lipid Res. 39, 633–646 (1998)
   Google Scholar
• Lookene A, Zhang L, Tougu V, Olivecrona: 1,1´-bis(anilino)-4-,4´-bis(naphtalene)-8,8´- disulfonate acts as an inhibitor of lipoprotein lipase and competes for binding with apolipoprotein CII. J. Biol. Chem. 278, 37183–37194 (2003)
   Google Scholar
• Cisar LA, Hoogewerf AJ, Cupp M, Rapport CA, Bensadoun A: Secretion and degradation of lipoprotein lipase in cultured adipocytes. Binding of lipoprotein lipase to membrane heparan sulfate proteoglycans is necessary for degradation. J. Biol. Chem. 264, 1767–1774 (1989)
   Google Scholar
• Hoogewerf AJ, Cisar LA, Evans DC, Bensadoun A: Effect of chlorate on the sulfation of lipoprotein lipase and heparan sulfate proteoglycans. Sulfation of heparan sulfate proteoglycans affects lipoprotein lipase degradation. J. Biol. Chem. 266, 16564–16571 (1991)
   Google Scholar
• Cisar LA, Melford KH, Sensel M, Bensadoun A: Heparin decreases the degradation rate of hepatic lipase in Fu5AH rat hepatoma cells. A model for hepatic lipase efflux from hepatocytes. Biochim. Biophys. Acta 1004, 196–204 (1989)
   Google Scholar
• Olivecrona T, Bengtsson-Olivecrona G: Lipoprotein lipase and hepatic lipase. Curr. Opin Lipidol. 4, 187–196 (1993)
   Google Scholar
• Chang S, Borensztajn J: Hepatic lipase function and the accumulation of -verylow- density lipoproteins in the plasma of cholesterol-fed rabbits. Biochem. J. 293, 745–750 (1993)
   Google Scholar
• Hegele RA, Little JA, Vezina C et al.: Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics. Arterioscler. Thromb. 13, 720–728 (1993)
   Google Scholar
• Jaye M, Lynch KJ, Krawiec J et al.: A novel endothelial-derived lipase that modulates HDL metabolism. Nat. Genet. 21, 424–428 (1999)
   Google Scholar
• Rader DJ, Jaye M: Endothelial lipase: a new member of the triglyceride lipase gene family. Curr. Opin Lipidol. 11, 141–147 (2000)
   Google Scholar
• Homanics GE, de Silva HV, Osada J et al.: Mild dyslipidemia in mice following targeted inactivation of the hepatic lipase gene. J. Biol. Chem. 270, 2974–2980 (1995)
   Google Scholar
• Ishida T, Choi S, Kundu RK et al.: Endothelial lipase is a major determinant of HDL level. J. Clin. Invest. 111, 347–355 (2003)
   Google Scholar
• Mead JR, Irvine SA, Ramji DP: Lipoprotein lipase: structure, function, regulation, and role in disease. J. Mol. Med. 80, 753–769 (2002)
   Google Scholar
• Schoonjans K, Peinado-Onsurbe J, Lefebvre AM, Heyman RA: PPAR and PPAR activators direct a distinct tissuespecific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J. 15, 5336–5348 (1996)
   Google Scholar
• Zhang Y, Repa JJ, Gauthier K, Mangelsdorf DJ: Regulation of lipoprotein lipase by the oxysterol receptors, LXR and LXR . J. Biol. Chem. 276, 43018–43024 (2001)
   Google Scholar
• Semenkovich CF, Wims M, Noe L, Etienne J, Chan L: Insulin regulation of lipoprotein lipase activity in 3T3-L1 adipocytes is mediated at posttranscriptional and posttranslational levels. J. Biol. Chem. 264, 9030–9038 (1989)
   Google Scholar
• Bergo M, Wu G, Ruge T, Olivecrona T: Down-regulation of adipose tissue lipoprotein lipase during fasting requires that a gene, separate from the lipase gene, is switched on. J. Biol. Chem. 277, 11927–11932 (2002)
   Google Scholar
• Bergo M, Olivecrona G, Olivecrona T: Forms of lipoprotein lipase in rat tissues: in adipose tissue the proportion of inactive lipase increases on fasting. Biochem. J. 313(Pt 3), 893–898 (1996)
   Google Scholar
• Sukonina V, Lookene A, Olivecrona T, Olivecrona G: Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc. Natl Acad. Sci. USA 103, 17450–17455 (2006)
   Google Scholar
• Ruge T, Bergo M, Hultin M, Olivecrona G, Olivecrona T: Nutritional regulation of binding sites for lipoprotein lipase in rat heart. Am. J. Physiol. Endocrinol. Metab. 278, E211–E218 (2000)
   Google Scholar
• Kiens B, Lithell H, Mikines KJ, Richter EA: Effects of insulin and exercise on muscle lipoprotein lipase activity in man and its relation to insulin action. J. Clin. Invest. 84, 1124–1129 (1989)
   Google Scholar
• Reina M, Brunzell JD, Deeb SS: Molecular basis of familial chylomicronemia: mutations in the lipoprotein lipase and apolipoprotein C-II genes. J. Lipid Res. 33, 1823–1832 (1992)
   Google Scholar
• Stalenhoef AFH, Malloy MJ, Kane JP, Havel RJ: Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans. Proc. Natl Acad. Sci. USA 81, 1839–1843 (1984)
   Google Scholar
• Weinstock PH, Bisgaier CL, Aalto-Setälä K et al.: Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired low density lipoprotein clearance in heterozygotes. J. Clin. Invest. 96, 2555–2568 (1995)
   Google Scholar
• Coleman T, Seip RL, Gimble JM, Lee D, Maeda N, Semenkovich CF: COOHterminal disruption of lipoprotein lipase in mice is lethal in homozygotes, but heterozygotes have elevated triglycerides and impaired enzyme activity. J. Biol. Chem. 270, 12518–12525 (1995)
   Google Scholar
• Acton SL, Scherer PE, Lodish HF, Krieger M: Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J. Biol. Chem. 269, 21003–21009 (1994)
   Google Scholar
• Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M: Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271, 518–520 (1996)
   Google Scholar
• Cardin AD, Jackson RL, Sparrow DA, Sparrow JT: Interaction of glycosaminoglycans with lipoproteins. Ann. NY Acad. Sci. 556, 186–193 (1989)
   Google Scholar
• Brown MS, Goldstein JL: A receptormediated pathway for cholesterol homeostasis. Science 232, 34–47 (1986)
   Google Scholar
• Lugemwa FN, Esko JD: Estradiol -Dxyloside, an efficient primer for heparan sulfate biosynthesis. J. Biol. Chem. 266, 6674–6677 (1991)
   Google Scholar
• Gi P, Beigneux AP, Davies B: Normal binding of lipoprotein lipase, chylomicrons, and apo-AV to GPIHBP1 containing a G56R amino acid substitution. Biochim. Biophys. Acta (2007) (In Press)
   Google Scholar
• Cardin AD, Hirose N, Blankenship DT, Jackson RL, Harmony JAK: Binding of a high reactive heparin to human apolipoprotein E: identification of two heparin-binding domains. Biochem. Biophys. Res. Commun. 134, 783–789 (1986)
   Google Scholar
• Cardin AD, Barnhart RL, Witt KR, Jackson RL: Reactivity of heparin with the human plasma heparin-binding proteins thrombin, antithrombin III, and apolipoproteins E and B-100. Thromb. Res. 34, 541–550 (1984)
   Google Scholar
• Lookene A, Beckstead JA, Nilsson S, Olivecrona G, Ryan RO: Apolipoprotein AV-heparin interactions: implications for plasma lipoprotein metabolism. J. Biol. Chem. 280, 25383–25387 (2005)
   Google Scholar
• Goldberg IJ, Wagner WD, Pang L et al.: The NH2-terminal region of apolipoprotein B is sufficient for lipoprotein association with glycosaminoglycans. J. Biol. Chem. 273, 35355–35361 (1998)
   Google Scholar
• Flood C, Gustafsson M, Richardson PE, Harvey SC, Segrest JP, Borén J: Identification of the proteoglycan binding site in apolipoprotein B48. J. Biol. Chem. 277, 32228–32233 (2002)
   Google Scholar
• Pennacchio LA, Olivier M, Hubacek JA et al.: An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294, 169–173 (2001)
   Google Scholar
• Calandra S, Oliva CP, Tarugi P, Bertolini S: APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency. Curr. Opin. Lipidol. 17, 122–127 (2006)
   Google Scholar
• Grosskopf I, Baroukh N, Lee SJ, Kamari Y: Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants. Arterioscler. Thromb. Vasc. Biol. 25, 2573–2579 (2005)
   Google Scholar
• Mahley RW: Expanding roles for apolipoprotein E in health and disease. In: Atherosclerosis XI. Jacotot B, Mathé D, Fruchart J-C (Eds). Elsevier Science, Amsterdam, The Netherlands 117–124 (1998)
   Google Scholar
• Teng B, Davidson NO: Evolution of intestinal apolipoprotein B mRNA editing. Chicken apolipoprotein B mRNA is not edited, but chicken enterocytes contain in vitro editing enhancement factor(s). J. Biol. Chem. 267, 21265–21272 (1992)
   Google Scholar
• Cunningham O, Andolfo A, Santovito ML, Iuzzolino L, Blasi F, Sidenius N: Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions. EMBO J. 22, 5994–6003 (2003)
   Google Scholar
• Varma R, Mayor S: GPI-anchored proteins are organized in submicron domains at the cell surface. Nature 394, 798–801 (1998)
   Google Scholar
• Kingsley DM, Krieger M: Receptormediated endocytosis of low density lipoprotein: somatic cell mutants define multiple genes required for expression of surface-receptor activity. Proc. Natl Acad. Sci. USA 81, 5454–5458 (1984).
   Google Scholar